Xigris



Indications and Reactions:

Role Indications Reactions
Primary
Sepsis 57.6%
Septic Shock 17.5%
Multi-organ Failure 5.1%
Pneumonia 3.9%
Sedation 2.1%
Shock 1.8%
Abdominal Sepsis 1.5%
Prophylaxis 1.5%
Urosepsis 1.3%
Antibiotic Therapy 1.0%
Thrombosis Prophylaxis 0.9%
Infection 0.8%
Hypotension 0.8%
Meningococcal Sepsis 0.8%
Autoimmune Hepatitis 0.7%
Supplementation Therapy 0.7%
Anticoagulant Therapy 0.6%
Mechanical Ventilation 0.6%
Blood Antidiuretic Hormone 0.5%
Multiple Myeloma 0.5%
Death 20.6%
Thrombocytopenia 15.4%
Platelet Count Decreased 10.2%
Sepsis 9.3%
Septic Shock 6.5%
Multi-organ Failure 5.5%
Haemorrhage 4.8%
Cardiac Arrest 3.3%
International Normalised Ratio Increased 3.2%
Respiratory Failure 3.2%
Haemorrhage Intracranial 3.0%
Hypotension 2.9%
Subarachnoid Haemorrhage 1.9%
Gastrointestinal Haemorrhage 1.8%
Pulmonary Haemorrhage 1.6%
Cerebral Haemorrhage 1.5%
General Physical Health Deterioration 1.5%
Pneumonia 1.5%
Wound Haemorrhage 1.3%
Pulmonary Embolism 1.1%
Secondary
Sepsis 26.6%
Septic Shock 9.4%
Drug Use For Unknown Indication 7.8%
Sedation 7.0%
Abdominal Sepsis 6.3%
Shock 6.3%
Thrombosis Prophylaxis 6.3%
Product Used For Unknown Indication 5.5%
Haemodynamic Instability 3.1%
Pneumonia 3.1%
Staphylococcal Sepsis 3.1%
Ill-defined Disorder 2.3%
Multi-organ Failure 2.3%
Antibiotic Therapy 1.6%
Blood Pressure Decreased 1.6%
Endotracheal Intubation 1.6%
Infection 1.6%
Prophylaxis 1.6%
Prophylaxis Against Transplant Rejection 1.6%
Renal Transplant 1.6%
Multi-organ Failure 16.2%
Sepsis 10.8%
Death 9.5%
Platelet Count Decreased 8.1%
Thrombocytopenia 6.8%
Tracheal Haemorrhage 6.8%
International Normalised Ratio Increased 5.4%
Ventricular Arrhythmia 5.4%
Pneumonia 4.1%
Troponin Increased 4.1%
Haemorrhage 2.7%
Medication Error 2.7%
Restlessness 2.7%
Septic Shock 2.7%
Therapy Non-responder 2.7%
Urinary Bladder Haemorrhage 2.7%
Wound Haemorrhage 2.7%
Clostridium Difficile Colitis 1.4%
Drug Ineffective 1.4%
General Physical Health Deterioration 1.4%
Concomitant
Drug Use For Unknown Indication 37.6%
Sepsis 10.6%
Product Used For Unknown Indication 9.9%
Septic Shock 7.8%
Pneumonia 5.0%
Systemic Candida 3.5%
Depression 2.8%
Escherichia Bacteraemia 2.8%
Haemodynamic Instability 2.8%
Hypotension 2.8%
Staphylococcal Infection 2.8%
Bacteraemia 1.4%
Convulsion 1.4%
Deep Vein Thrombosis 1.4%
Endocarditis Staphylococcal 1.4%
Pain 1.4%
Preoperative Care 1.4%
Systemic Lupus Erythematosus 1.4%
Anaemia 0.7%
Anticoagulant Therapy 0.7%
Septic Shock 18.2%
Cytolytic Hepatitis 12.1%
Vasculitis 9.1%
Hypoglycaemia 6.1%
Pyrexia 6.1%
Toxic Epidermal Necrolysis 6.1%
Anxiety 3.0%
Breast Enlargement 3.0%
Cardio-respiratory Arrest 3.0%
Circulatory Collapse 3.0%
Death 3.0%
Disability 3.0%
Drug Ineffective 3.0%
Drug Level Decreased 3.0%
Eosinophilic Pneumonia 3.0%
Multi-organ Failure 3.0%
Ototoxicity 3.0%
Pneumonitis 3.0%
Purpura 3.0%
Rash Macular 3.0%